Company intelligence / Profile preview

Surgify Medical

Helsinki/Espoo, Finlandsurgifymedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

Surgify Halo™ has regulatory approval under MDR and FDA 510(k), is commercially available in the EU and US, has been used successfully in over a thousand patient procedures with strong surgeon preference for its safety profile. The device provides effective bone cutting while protecting soft tissues from incidental injury.

Therapeutic areas: OtherOncologyNeurology
Modalities: Device (specifically, surgical power tool/bone drill)
Industry: Surgical Medical Devices

Partnerships

ZEISS Ventures / Carl Zeiss Group (strategic investor/funding partner)

Beyond the preview

Go deeper on Surgify Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Surgify Medical.

Explore the full profile